HUA MEDICINE revenue for the last year amounted to 82.96 M HKD, the most of which — 84.65 M HKD — came from its highest performing source at the moment, Dorzagliatin, the year earlier bringing 20.47 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought HUA MEDICINE 84.65 M HKD, and the year before that — 20.47 M HKD.